TP53 mutations present a higher frequency and RUNX1 and KMT2A fusions present a lower frequency in adult AML compared to in other age groups, and both are associated with a poor prognosis, whereas complex karyotypes are considered quite common [11]. This evidence concerns the gene KMT2A and acute myeloid leukemia.